Family Manage LLC Sells 31,307 Shares of Nutrien Ltd. $NTR

Family Manage LLC lowered its stake in shares of Nutrien Ltd. (NYSE:NTR) by 40.9% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 45,312 shares of the company’s stock after selling 31,307 shares during the quarter. Family Manage LLC’s holdings in Nutrien were worth $3,410,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Guggenheim Capital LLC raised its position in shares of Nutrien by 2.2% during the fourth quarter. Guggenheim Capital LLC now owns 6,628 shares of the company’s stock valued at $409,000 after buying an additional 145 shares during the last quarter. Minot DeBlois Advisors LLC grew its position in Nutrien by 1.8% during the fourth quarter. Minot DeBlois Advisors LLC now owns 9,032 shares of the company’s stock worth $557,000 after buying an additional 164 shares in the last quarter. Banque Cantonale Vaudoise increased its stake in Nutrien by 15.9% during the first quarter. Banque Cantonale Vaudoise now owns 1,198 shares of the company’s stock valued at $90,000 after acquiring an additional 164 shares during the period. Gould Asset Management LLC CA increased its stake in Nutrien by 4.4% during the first quarter. Gould Asset Management LLC CA now owns 3,933 shares of the company’s stock valued at $297,000 after acquiring an additional 165 shares during the period. Finally, EverSource Wealth Advisors LLC raised its holdings in Nutrien by 21.8% in the 4th quarter. EverSource Wealth Advisors LLC now owns 983 shares of the company’s stock valued at $61,000 after acquiring an additional 176 shares in the last quarter. 63.10% of the stock is currently owned by institutional investors and hedge funds.

Nutrien Price Performance

Nutrien stock opened at $68.18 on Monday. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.59 and a current ratio of 1.24. The firm has a market cap of $32.61 billion, a P/E ratio of 13.89, a P/E/G ratio of 0.67 and a beta of 0.62. The business’s fifty day moving average is $66.52 and its two-hundred day moving average is $70.09. Nutrien Ltd. has a 52 week low of $53.03 and a 52 week high of $85.36.

Nutrien (NYSE:NTR) last announced its earnings results on Wednesday, May 6th. The company reported $0.51 EPS for the quarter, topping the consensus estimate of $0.48 by $0.03. Nutrien had a return on equity of 8.84% and a net margin of 8.58%.The company had revenue of $6.05 billion for the quarter, compared to analysts’ expectations of $5.30 billion. During the same quarter in the prior year, the business earned $0.11 earnings per share. The business’s revenue for the quarter was up 18.5% on a year-over-year basis. Equities research analysts forecast that Nutrien Ltd. will post 5.08 earnings per share for the current fiscal year.

Nutrien Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, July 17th. Investors of record on Tuesday, June 30th were given a dividend of $0.55 per share. The ex-dividend date was Tuesday, June 30th. This represents a $2.20 annualized dividend and a yield of 3.2%. Nutrien’s dividend payout ratio is 44.81%.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on NTR shares. National Bank Financial set a $76.00 target price on Nutrien and gave the company an “outperform” rating in a research note on Monday, July 13th. Raymond James Financial upgraded shares of Nutrien from a “market perform” rating to an “outperform” rating and lifted their price target for the stock from $74.00 to $90.00 in a research note on Tuesday, May 5th. Bank of America raised shares of Nutrien from a “neutral” rating to a “buy” rating and set a $82.00 price target on the stock in a report on Thursday, April 30th. Canadian Imperial Bank of Commerce dropped their price objective on shares of Nutrien from $90.00 to $88.00 and set an “outperformer” rating for the company in a research note on Thursday, April 30th. Finally, UBS Group reduced their price objective on shares of Nutrien from $67.00 to $65.00 and set a “sell” rating for the company in a report on Monday, May 11th. Fourteen equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Nutrien presently has a consensus rating of “Moderate Buy” and a consensus target price of $81.89.

Nutrien Company Profile

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.